If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring ... Ocrevus Zunovo is approved for the treatment of primary progressive MS and relapsing forms of MS, including ...

Multiple sclerosis (MS) is one of the most widespread ... most people have relapsing-remitting MS. Other types include primary progressive MS, secondary progressive MS, and clinically isolated ...

According to the MS Society, certain medications like ocrelizumab (Ocrevus) can slow the progression of the disease in primary progressive multiple sclerosis, and syponimod (Mayzent) can help with ...

Its pipeline products include PIPE-791, an LPA1 receptor antagonist for idiopathic pulmonary fibrosis (IPF) and progressive multiple sclerosis (PMS); PIPE-307, a selective inhibitor of the M1 receptor ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Disappointingly, evobrutinib did not outperform teriflunomide on the primary outcome ... smouldering multiple sclerosis activity. Considering these results, BTK inhibitors as a class might be less ...

ABA-101 is under clinical development by Abata Therapeutics and currently in Phase I for Primary Progressive Multiple Sclerosis (PPMS). According to GlobalData, Phase I drugs for Primary Progressive ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow ...